Disseminated Gastrointestinal Mucormycosis in Immunocompromised Disease

키워드

참고문헌 (20)

1. Petrikkos G, "Epidemiology and clinical manifestations of mucormycosis", Clin Infect Dis, 54(Suppl 1), pp.S23~S34 (2012)
2. Gonzalez CE, "Zygomycosis", Infect Dis Clin North Am, 16, pp.895~914 (2002)
3. Petrikkos G, "Zygomycosis in Immunocompromised non-Haematological Patients", Mediterr J Hematol Infect Dis, 3, pp.e2011012~ (2011)
4. Prabhu RM, "Mucormycosis and entomophthoramycosis:a review of the clinical manifestations, diagnosis and treatment", Clin Microbiol Infect, 10(Suppl 1), pp.31~47 (2004)
5. Ribes JA, "Zygomycetes in human disease", Clin Microbiol Rev, 13, pp.236~301 (2000)
6. Roden MM, "Epidemiology and outcome of zygomycosis: a review of 929 reported cases", Clin Infect Dis, 41, pp.634~653 (2005)
7. Agha FP, "Mucormycoma of the colon: early diagnosis and successful management", AJR Am J Roentgenol, 145, pp.739~741 (1985)
8. Lo OS, "Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon’s perspective", World J Gastroenterol, 16, pp.1165~1170 (2010)
9. Lee SH, "Successful treatment of invasive gastric mucormycosis in a patient with alcoholic liver cirrhosis: a case report", Exp Ther Med, 8, pp.401~404 (2014)
10. Yang YC, "A case of mucormycosis colonization associated with giant gastric ulcer", Korean J Gastrointest Endosc, 20, pp.49~52 (2000)
11. 한재용, "급성골수성백혈병 환자에서 대장내시경으로 진단된 회장 모균증", 대한소화기학회지, 52(3), pp.179~182 (2008), 대한소화기학회
12. Suh IW, "Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia", J Korean Med Sci, 15, pp.351~354 (2000)
13. Kontoyiannis DP, "Zygomycosis in the 1990s in a tertiary-care cancer center", Clin Infect Dis, 30, pp.851~856 (2000)
14. Kontoyiannis DP, "Invasive zygomycosis:update on pathogenesis, clinical manifestations, and management", Infect Dis Clin North Am, 20, pp.581~607 (2006)
15. Spellberg B, "Recent advances in the management of mucormycosis: from bench to bedside", Clin Infect Dis, 48, pp.1743~1751 (2009)
16. Gómez-López A, "In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole", J Antimicrob Chemother, 48, pp.919~921 (2001)
17. van Burik JA, "Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91cases", Clin Infect Dis, 42, pp.e61~e65 (2006)
18. Liles WC, "Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens", J Infect Dis, 175, pp.1012~1015 (1997)
19. Garcia-Diaz JB, "Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colonystimulating factor", Clin Infect Dis, 32, pp.e145~e150 (2001)
20. Vaes M, "Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome", Antimicrob Agents Chemother, 56, pp.6298~6303 (2012)